graphic
News > Companies
Pfizer beats 1Q forecasts
April 18, 2000: 8:42 a.m. ET

Strong sales of drugs, gain from sales of investment bring record income
graphic
graphic graphic
graphic
NEW YORK (CNNfn) - Drug maker Pfizer Inc. beat first-quarter earnings estimates Tuesday, driven by strong revenue growth.
    The New York-based company had earnings of $1.1 billion, or 28 cents a diluted share, excluding a special gain, up 33 percent from net income of $815 million, or 21 cents a share, in the year-earlier period. Analysts surveyed by earnings tracker First Call forecast the company to make 25 cents a share in the period.
    Pfizer (PFE: Research, Estimates) saw a $135 million pretax gain from the sale of research-related equity investments in the first quarter. Including that, net income for the period climbed to a record $1.2 billion, or 31 cents a diluted share.
    graphicRevenue rose 10 percent to $4.3 billion from $3.9 billion. The biggest gain came from alliance revenue, which posted a 65 percent increase to $665 million, while net sales rose a more modest 4 percent to $3.7 billion. Revenue from the sale of pharmaceuticals rose 11 percent in the period, and would have shown a 15-percent increase without the impact of currency fluctuations.
    Pfizer reached agreement to buy competitor Warner-Lambert Co. in February in a deal then valued at $90 billion, after launching a hostile bid for Warner-Lambert (WLA: Research, Estimates) late last year to block its proposed merger with American Home Products Corp. (AHP: Research, Estimates)
    Shares of Pfizer edged up 1/16 to 38 in Monday trading. Back to top

  RELATED STORIES

Pfizer and Warner-Lambert consummate courtship - Feb. 07, 2000

Pfizer exceeds 4Q forecasts - Jan. 18, 2000





graphic


© 2009 Cable News Network. A Time Warner Company. All Rights Reserved. Terms under which this service is provided to you. Privacy Policy
Copyright © 2009 BigCharts.com Inc. All rights reserved. Please see our Terms of Use.
MarketWatch, the MarketWatch logo, and BigCharts are registered trademarks of MarketWatch, Inc.
Intraday data provided by Interactive Data Real-Time Services and subject to the Terms of Use.
Intraday data is at least 20-minutes delayed. All times are ET.
Historical, current end-of-day data, and splits data provided by Interactive Data Pricing and Reference Data.
Fundamental data provided by Morningstar, Inc..
SEC Filings data provided by Edgar Online Inc..
Earnings data provided by FactSet CallStreet, LLC.